Apellis Pharmaceuticals Inc

Deals

View up-to-date information on Apellis Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into key Apellis Pharmaceuticals Inc mergers and acqusitions.

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
27 Oct 2020 Apellis Pharma and Swedish Orphan Biovitrum AB (Sobi) Enter into Collaboration Partnership Apellis Pharmaceuticals Inc; Swedish Orphan Biovitrum AB
28 May 2020 Apellis Pharmaceuticals Inc Enters Phase I/II Clinical Trial Agreement with Worldwide Clinical Trials Holdings Inc for APL-9 (GDCT0386973) Contract Service Agreement Apellis Pharmaceuticals Inc Worldwide Clinical Trials Holdings Inc
11 Sep 2019 Apellis Pharma Raises USD220 Million in Private Placement of 3.5% Convertible Senior Notes Due 2026 Debt Offering Apellis Pharmaceuticals Inc
06 Mar 2019 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
28 Feb 2019 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
28 Feb 2019 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit